DE69929189T2 - Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche - Google Patents

Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche Download PDF

Info

Publication number
DE69929189T2
DE69929189T2 DE69929189T DE69929189T DE69929189T2 DE 69929189 T2 DE69929189 T2 DE 69929189T2 DE 69929189 T DE69929189 T DE 69929189T DE 69929189 T DE69929189 T DE 69929189T DE 69929189 T2 DE69929189 T2 DE 69929189T2
Authority
DE
Germany
Prior art keywords
afp
aap
reversible equilibrium
complex according
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929189T
Other languages
German (de)
English (en)
Other versions
DE69929189D1 (de
Inventor
Oleg Strelchenok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardenia Investments Ltd
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Application granted granted Critical
Publication of DE69929189D1 publication Critical patent/DE69929189D1/de
Publication of DE69929189T2 publication Critical patent/DE69929189T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69929189T 1998-06-17 1999-06-17 Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche Expired - Lifetime DE69929189T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802162 1998-06-17
SE9802162A SE9802162D0 (sv) 1998-06-17 1998-06-17 Immunostimulating composition
PCT/EP1999/004201 WO1999065936A2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Publications (2)

Publication Number Publication Date
DE69929189D1 DE69929189D1 (de) 2006-02-02
DE69929189T2 true DE69929189T2 (de) 2006-08-31

Family

ID=20411743

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929189T Expired - Lifetime DE69929189T2 (de) 1998-06-17 1999-06-17 Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche

Country Status (10)

Country Link
US (1) US6599507B2 (enExample)
EP (1) EP1085909B1 (enExample)
JP (1) JP4392991B2 (enExample)
AT (1) ATE314094T1 (enExample)
AU (1) AU748838B2 (enExample)
BR (1) BR9911294B1 (enExample)
CA (1) CA2335079C (enExample)
DE (1) DE69929189T2 (enExample)
SE (1) SE9802162D0 (enExample)
WO (1) WO1999065936A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
JP4515642B2 (ja) * 1999-03-16 2010-08-04 アーデニア・インベストメンツ・リミテッド 多価不飽和脂肪酸誘導体およびその使用
ATE339429T1 (de) * 2000-07-12 2006-10-15 Ardenia Investments Ltd Neue cytotoxische verbindungen und deren verwendung
US20070111936A1 (en) * 2005-11-15 2007-05-17 Vladimir Pak Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
HK1035866A1 (en) 2001-12-14
JP2004500315A (ja) 2004-01-08
BR9911294A (pt) 2002-01-02
US20010034324A1 (en) 2001-10-25
SE9802162D0 (sv) 1998-06-17
EP1085909A2 (en) 2001-03-28
JP4392991B2 (ja) 2010-01-06
AU4773499A (en) 2000-01-05
US6599507B2 (en) 2003-07-29
WO1999065936A3 (en) 2000-02-10
BR9911294B1 (pt) 2012-01-10
EP1085909B1 (en) 2005-12-28
WO1999065936A2 (en) 1999-12-23
CA2335079A1 (en) 1999-12-23
ATE314094T1 (de) 2006-01-15
CA2335079C (en) 2008-01-08
DE69929189D1 (de) 2006-02-02
AU748838B2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
Kumar et al. Angiogenesis factor from human myocardial infarcts
DE69732225T2 (de) Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
DE3027105A1 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors
DE69332688T2 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
DD209634A5 (de) Verfahren zur herstellung neuer glykoproteine und deren verwendung in therapeutischen mitteln gegen tumore
DE9390311U1 (de) Neue Makrophagen mit Eignung als Wirkstoffe von pharmazeutischen Zusammensetzungen
DE3448144C2 (enExample)
DE69432313T2 (de) Neuartiges sythetisches Peptil, diese enthaltende Zusammensetzung und Arznei-Zusammensetzung und Arznei gegen das Atemnotsyndrom
DE2635065C2 (de) Verfahren zur halbkontinuierlichen Behandlung von Gesamtblut zur Herstellung von biologisch aktiven hämatopoetischen Chalonextrakten
EP0358130B1 (de) Mittel mit immunsuppressiver Wirkung
DE69830842T9 (de) Peptide als kalium kanalaktivatoren
EP0145005B1 (de) Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE3109335A1 (de) Die neue, physiologisch wirksame substanz ebelacton und verfahren zur herstellung derselben
DE69228061T2 (de) Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum
DE68912582T2 (de) Anti-hiv-mittel.
JP4392991B2 (ja) 免疫不全症の処置のための組成物、およびその調製と使用のための方法
EP0500844B1 (de) Arzneimittel enthaltend cd14
DE69532557T2 (de) Zubereitung enthaltend Glykane übereinstimmend mit Transferrin Glykaner als aktives Prinzip für die Induktion der Immuntoleranz gegen Antigene
DE68928646T2 (de) Natriuretisches hormon
DE60024969T2 (de) 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
DE2428955B2 (de) Verfahren zur Abtrennung der enzymatischen Komponente mit in vivo antikoagulierender und in vitro koagulierender Wirkung aus dem Gift der Schlange Ancistrodon rhodostoma und daraus hergestellte Mittel
DE69909137T2 (de) Polyungesättigte Fettsäurederivate und deren Verwendung in der Krebsbehandlung
DE3880758T2 (de) Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.
DE69434256T2 (de) Immunglobulin-Infusion bei der Xenotransplantation
DE3633797C2 (de) Verfahren zur Gewinnung von biologisch aktiven Eiweissen (Peptiden) aus menschlichem und tierischem Blut (bzw. anderen Körperflüssigkeiten)

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ARDENIA INVESTMENTS LTD., LONDON, GB

8364 No opposition during term of opposition